hr@fordozpharma.com
+1 (609) 469-5949

ForDoz Pharma Corp. Announces FDA Approval of DOXOrubicin Hydrochloride Liposome Injection

News & Updates
Latest news and insights
ForDoz-Pharma-Corp.-Announces-FDA-Approval-of-DOXOrubicin-Hydrochloride-Liposome-Injection
July 23, 2024
ForDoz Pharma Corp. Announces FDA Approval of DOXOrubicin Hydrochloride Liposome Injection
ForDoz Pharma Corp., a private specialty pharmaceutical company focused on product development, manufacturing and commercialization of
Read More